What is the Anlon Healthcare PB ratio (price to book value)?
Anlon Healthcare's price-to-book (PB) ratio is 5.19 at the 29 October 2026 close: a market capitalisation of ₹1,335 crore divided by shareholders' equity (book value) of ₹257 crore on 30 September 2026. That is a book value of ₹4.84 per share against a share price of ₹25.11.
What is the Anlon Healthcare net worth?
Anlon Healthcare's net worth — shareholders' equity in its consolidated balance sheet — was ₹257 crore on 30 September 2026. Its market value is a different figure: a market capitalisation of ₹1,335 crore at the 29 October 2026 close.
What is the Anlon Healthcare book value per share?
Anlon Healthcare's book value per share was ₹4.84 on 30 September 2026: shareholders' equity of ₹257 crore divided by the 53.15 crore shares in issue. The share price at the 29 October 2026 close was ₹25.11.
What is the Anlon Healthcare market cap?
Anlon Healthcare's market capitalisation was ₹1,335 crore at the 29 October 2026 close: 53.15 crore shares at ₹25.11 each.
Is Anlon Healthcare debt free?
No. Anlon Healthcare had borrowings of ₹72.3 crore on 30 September 2026 (consolidated balance sheet), a debt-to-equity ratio of 0.24. Its cash and current investments were ₹8 crore, so its net debt was ₹64.3 crore.
What is the Anlon Healthcare debt to equity ratio?
Anlon Healthcare's debt-to-equity ratio was 0.24 on 30 September 2026: borrowings of ₹72.3 crore against total equity of ₹296 crore.
What is the Anlon Healthcare EPS?
Anlon Healthcare's basic earnings per share (EPS) were ₹6.11 in FY26.
What is the Anlon Healthcare promoter holding?
Promoters held 52.68% of Anlon Healthcare on 30 September 2026, unchanged from both the previous quarter and a year earlier, according to the shareholding pattern filed with NSE.
What is the Anlon Healthcare free cash flow?
In FY26, Anlon Healthcare generated ₹79.4 crore of cash from operations and spent ₹0 lakh on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of −₹79.4 crore.
What is the Anlon Healthcare shareholding pattern?
On 30 September 2026, Anlon Healthcare's shares were held by promoters 52.68%, foreign portfolio investors (FII/FPI) 1.00%, domestic institutions (DII) 0.30% (including mutual funds at 0.00%) and retail and other non-institutional investors 46.02%. Over the year, FII holding was up 1.00 percentage points from 0.00% and DII holding was down 2.53 percentage points from 2.83%.
How does the Anlon Healthcare PE ratio compare with its peers?
At the 29 October 2026 closing prices, on FY26 net profit attributable to shareholders, Anlon Healthcare's PE ratio is 46.8, the second highest of the three: Anuh Pharma 19.5 and Bajaj Healthcare 66.8, a peer average of 43.1. Each is the company's market capitalisation at that price divided by its FY26 net profit.
Anlon Healthcare vs Anuh Pharma: how do they compare?
In FY26, Anlon Healthcare earned net profit attributable to shareholders of ₹28.5 crore on revenue of ₹172 crore, against ₹41 crore on ₹772 crore for Anuh Pharma. Anlon Healthcare's operating margin was 26.8% (Anuh Pharma 6.5%). At the 29 October 2026 close, Anlon Healthcare's market capitalisation was ₹1,335 crore against ₹799 crore for Anuh Pharma, and its PE ratio on FY26 profit 46.8 against 19.5.
What are the Anlon Healthcare latest quarterly results?
Anlon Healthcare's latest results are for Q2 FY27 (July–September 2026), filed on 29 October 2026: consolidated net profit attributable to shareholders ₹13.4 crore; revenue from operations ₹106 crore.
When are the Anlon Healthcare next results?
Anlon Healthcare has reported Q2 FY27. Its next results, for Q3 FY27 (October–December 2026), are due by 14 February 2027 under SEBI's 45-day rule; the company notifies the board-meeting date at least two working days before.
How does Anlon Healthcare compare with its peers?
On FY26 consolidated figures, against Anuh Pharma and Bajaj Healthcare: Anlon Healthcare's operating margin of 26.8% is the highest of the three (Anuh Pharma 6.5%, Bajaj Healthcare 12.7%; peer average 9.6%).
What is the Anlon Healthcare revenue and profit in FY26?
In FY26 (April 2025–March 2026), Anlon Healthcare's consolidated net profit attributable to shareholders was ₹28.5 crore, on revenue from operations of ₹172 crore.
Consolidated figures from the company's filings with NSE; prices are NSE closing prices.
